Improving short antimicrobial peptides despite elusive rules for activity.

Antimicrobial peptides (AMPs) can effectively kill a broad range of life threatening multidrug-resistant bacteria, a serious threat to public health worldwide. However, despite great hopes novel drugs based on AMPs are still rare. To accelerate drug development we studied different approaches to improve the antibacterial activity of short antimicrobial peptides. Short antimicrobial peptides seem to be ideal drug candidates since they can be synthesized quickly and easily, modified and optimized. In addition, manufacturing a short peptide drug will be more cost efficient than long and structured ones. In contrast to longer and structured peptides short AMPs seem hard to design and predict. Here, we designed, synthesized and screened five different peptide libraries, each consisting of 600 9-mer peptides, against Pseudomonas aeruginosa. Each library is presenting a different approach to investigate effectiveness of an optimization strategy. The data for the 3000 peptides were analyzed using models based on fuzzy logic bioinformatics and plausible descriptors. The rate of active or superior active peptides was improved from 31.0% in a semi-random library from a previous study to 97.8% in the best new designed library. This article is part of a Special Issue entitled: Antimicrobial peptides edited by Karl Lohner and Kai Hilpert.

[1]  Artem Cherkasov,et al.  BIOINFORMATICS ORIGINAL PAPER doi:10.1093/bioinformatics/btm068 Databases and ontologies AMPer: a database and an automated discovery tool for antimicrobial peptides , 2022 .

[2]  D. Pompliano,et al.  Drugs for bad bugs: confronting the challenges of antibacterial discovery , 2007, Nature Reviews Drug Discovery.

[3]  S. Leong,et al.  Design of short membrane selective antimicrobial peptides containing tryptophan and arginine residues for improved activity, salt‐resistance, and biocompatibility , 2014, Biotechnology and bioengineering.

[4]  C. Bloch,et al.  Antiplasmodial and antileishmanial activities of phylloseptin-1, an antimicrobial peptide from the skin secretion of Phyllomedusa azurea (Amphibia). , 2009, Experimental parasitology.

[5]  R. Hancock,et al.  Mode of Action of the Antimicrobial Peptide Indolicidin* , 1996, The Journal of Biological Chemistry.

[6]  R. Hancock,et al.  Short Cationic Antimicrobial Peptides Interact with ATP , 2010, Antimicrobial Agents and Chemotherapy.

[7]  Dirk Lange,et al.  The biocompatibility and biofilm resistance of implant coatings based on hydrophilic polymer brushes conjugated with antimicrobial peptides. , 2011, Biomaterials.

[8]  Markus Reischl,et al.  Targeting Mycobacterium tuberculosis and Other Microbial Pathogens Using Improved Synthetic Antibacterial Peptides , 2013, Antimicrobial Agents and Chemotherapy.

[9]  S. Avram,et al.  Evaluation of Antimicrobial Activity of New Mastoparan Derivatives Using QSAR and Computational Mutagenesis , 2011, International Journal of Peptide Research and Therapeutics.

[10]  S. Panguluri,et al.  Recent patents on antimicrobial peptides. , 2010, Recent patents on DNA & gene sequences.

[11]  Kai Hilpert,et al.  High-throughput generation of small antibacterial peptides with improved activity , 2005, Nature Biotechnology.

[12]  Ralf Mikut,et al.  Interpretable Features for the Activity Prediction of Short Antimicrobial Peptides Using Fuzzy Logic , 2009, International Journal of Peptide Research and Therapeutics.

[13]  Artem Cherkasov,et al.  Use of artificial intelligence in the design of small peptide antibiotics effective against a broad spectrum of highly antibiotic-resistant superbugs. , 2009, ACS chemical biology.

[14]  Kai Hilpert,et al.  Use of luminescent bacteria for rapid screening and characterization of short cationic antimicrobial peptides synthesized on cellulose using peptide array technology , 2007, Nature Protocols.

[15]  R. Hancock,et al.  Deciphering the Mode of Action of the Synthetic Antimicrobial Peptide Bac8c , 2011, Antimicrobial Agents and Chemotherapy.

[16]  Kai Hilpert,et al.  Easy Strategy To Protect Antimicrobial Peptides from Fast Degradation in Serum , 2010, Antimicrobial Agents and Chemotherapy.

[17]  K. Hilpert,et al.  Screening for Antifungal Peptides and Their Modes of Action in Aspergillus nidulans , 2010, Applied and Environmental Microbiology.

[18]  R. Hancock,et al.  Peptide Antimicrobial Agents , 2006, Clinical Microbiology Reviews.

[19]  R. Allaker.  Host defence peptides-a bridge between the innate and adaptive immune responses. , 2008, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[20]  M. V. Nogués,et al.  Discovering new in silico tools for antimicrobial peptide prediction. , 2012, Current drug targets.

[21]  Ralf Mikut,et al.  Computer-based analysis, visualization, and interpretation of antimicrobial peptide activities. , 2010, Methods in molecular biology.

[22]  Kai Hilpert,et al.  Peptide arrays on cellulose support: SPOT synthesis, a time and cost efficient method for synthesis of large numbers of peptides in a parallel and addressable fashion , 2007, Nature Protocols.

[23]  C. Fjell,et al.  Identification of novel antibacterial peptides by chemoinformatics and machine learning. , 2009, Journal of medicinal chemistry.

[24]  R. Hancock,et al.  Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances , 2008, Nature Protocols.

[25]  R. Houghten,et al.  Synthetic combinatorial libraries: novel discovery strategy for identification of antimicrobial agents , 1996, Antimicrobial agents and chemotherapy.

[26]  Gajendra P. S. Raghava,et al.  Analysis and prediction of antibacterial peptides , 2007, BMC Bioinformatics.

[27]  H. Vogel,et al.  Tryptophan- and arginine-rich antimicrobial peptides: structures and mechanisms of action. , 2006, Biochimica et biophysica acta.

[28]  H. Sahl,et al.  Modulating the activity of short arginine-tryptophan containing antibacterial peptides with N-terminal metallocenoyl groups , 2012, Beilstein journal of organic chemistry.